knowledge -WSS

knowledge

author：entertainment 2025-09-06 03:53:45 - browse：7225

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.

Pfizer said the boy died of cardiac arrest, but that it was still working to understand what happened and the exact cause.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Greece's new parliament sworn in following conservative party's election victory

knowledge

WSS

Health officials lay out plans to cope with respiratory virus season

How the drug

3 killed, 8 injured in late

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

Trans patients at the end of life deserve respect and dignity

People can get long Covid without testing positive for virus: Study

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Apple is now the first public company to be valued at $3 trillion

Vivek Ramaswamy made waves in the debate, much as in biotech

Affirmative action in medical school literally saved lives

How the first Native Hawaiian psychiatrist helped diversify medicine

Medicare proposal to cover medical devices draws a mixed reaction

How to make over

Drug repurposing or repositioning? The language matters

Intellia plays down concerns on accidental germline transmission

focus

As obesity drug market grows, telehealth companies court payers

PBMs are inflating the cost of generic drugs. They must be reined in

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

Leon Gautier, last member of French D

Former Pear Therapeutics executives start new VC firm

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

knowledge

leisure time

focus

Wikipedia